| Entry |
|
|---|
| Name |
Amlodipine maleate (USAN);
Amvaz (TN) |
|---|
| Formula |
C20H25ClN2O5. C4H4O4
|
|---|
| Exact mass |
524.1562
|
|---|
| Mol weight |
524.9481
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01575 Calcium channel blocker
DG01496 Calcium channel L type blocker
DG03231 Antihypertensive
DG01928 Dihydropyridine calcium channel blocker
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
|---|
| Remark |
| Product (DG00322): | D00615<JP/US> D11881<US> |
| Product (mixture): | D10805<JP> D11069<US> |
|
|---|
| Efficacy |
Antihypertensive, Vasodilator, Calcium channel blocker |
|---|
| Comment |
Dihydropyridine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04261 | Adrenergic signaling in cardiomyocytes |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C08 CALCIUM CHANNEL BLOCKERS
C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
C08CA Dihydropyridine derivatives
C08CA01 Amlodipine
D02914 Amlodipine maleate (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01575 Calcium channel blocker
DG01496 Calcium channel L type blocker
DG00322 Amlodipine
D02914 Amlodipine maleate
DG03231 Antihypertensive
DG01928 Dihydropyridine calcium channel blocker
DG00322 Amlodipine
D02914 Amlodipine maleate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00322 Amlodipine
D02914 Amlodipine maleate
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA1-L
D02914 Amlodipine maleate (USAN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02914
Drug groups [BR:br08330]
Cardiovascular agent
DG01575 Calcium channel blocker
DG01496 Calcium channel L type blocker
DG00322 Amlodipine
DG03231 Antihypertensive
DG01928 Dihydropyridine calcium channel blocker
DG00322 Amlodipine
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00322 Amlodipine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 36
1 C6a C 28.6629 -16.1156
2 O6a O 29.3546 -17.3137
3 O6a O 31.2223 -17.3137
4 C6a C 31.9140 -16.1156
5 C2b C 31.2223 -14.9175
6 C2b C 29.3546 -14.9175
7 O6a O 33.2975 -16.1156
8 O6a O 27.2794 -16.1156
9 C1y C 21.0168 -13.2762
10 C2y C 22.1998 -12.5803
11 C2y C 19.8339 -12.5803
12 C8y C 21.0168 -15.6421
13 C2y C 22.1998 -11.1886
14 C7a C 23.3828 -13.2762
15 C2y C 19.8339 -11.1886
16 C7a C 18.6509 -13.2066
17 C8y C 22.1998 -16.3380
18 C8x C 19.8339 -16.3380
19 N1x N 21.0168 -10.4927
20 C1b C 23.3828 -10.4927
21 O7a O 24.5658 -12.5803
22 O6a O 23.3828 -14.5983
23 C1a C 18.6509 -10.4927
24 O7a O 17.4679 -12.5803
25 O6a O 18.6509 -14.5983
26 C8x C 22.1998 -17.6601
27 X Cl 23.3828 -15.6421
28 C8x C 19.8339 -17.6601
29 O2a O 24.5658 -11.1886
30 C1b C 25.7487 -13.2762
31 C1a C 16.2849 -13.2066
32 C8x C 21.0168 -18.3560
33 C1b C 25.7487 -10.4927
34 C1a C 26.9317 -12.5803
35 C1b C 26.9317 -11.1886
36 N1a N 28.1147 -10.4927
BOND 36
1 1 2 2
2 3 4 1
3 4 5 1
4 5 6 2
5 1 6 1
6 4 7 2
7 1 8 1
8 9 10 1
9 9 11 1
10 9 12 1
11 10 13 2
12 10 14 1
13 11 15 2
14 11 16 1
15 12 17 1
16 12 18 2
17 13 19 1
18 13 20 1
19 14 21 1
20 14 22 2
21 15 23 1
22 16 24 1
23 16 25 2
24 17 26 2
25 17 27 1
26 18 28 1
27 20 29 1
28 21 30 1
29 24 31 1
30 26 32 1
31 29 33 1
32 30 34 1
33 33 35 1
34 35 36 1
35 15 19 1
36 28 32 2
|
|---|
